CMS certification 100073
Holy Cross Hospital
4725 N Federal Hwy, Ft Lauderdale, FL 33308
Holy Cross Hospital has a CMS overall rating of 4 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1. Emergency patients spend a median of 2 h 39 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,092 completed surveys, 26% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | FL | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 391 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 39 min | 2 h 36 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 11 visits sampled | 3 h 27 min | 3 h 40 min | 4 h 17 min |
| Left before being seen Lower is better · 61,905 patients | 2% | 1% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 199 patients | 67% | 73% | 65% |
How Holy Cross Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Holy Cross HospitalThis hospital | 4/5 | 69% | 2 h 39 min | 3 better 1 worse |
| Broward Health Imperial PointSame county · Fort Lauderdale | 3/5 | 73% | 2 h 22 min | 1 better 1 worse |
| Broward Health Medical CenterSame county · Fort Lauderdale | 3/5 | 65% | 3 h 3 min | 3 better 2 worse |
| HCA Florida Mercy HospitalSame county · Plantation | 2/5 | 67% | 2 h 14 min | 4 better 2 worse |
| University Hospital and Medical CenterSame county · Tamarac | 2/5 | 58% | 2 h 13 min | 1 better 3 worse |
| Westside Regional Medical CenterSame county · Plantation | 2/5 | 60% | 2 h 1 min | 4 better 3 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,342 cases | Too few cases | 4% | 3.9% |
| Heart attack 251 cases | Too few cases | 10.9% | 11.9% |
| Heart failure 474 cases | Too few cases | 10.1% | 11.1% |
| Pneumonia 626 cases | Too few cases | 14.4% | 15.2% |
| Stroke 377 cases | Too few cases | 12.8% | 11.9% |
| COPD 204 cases | Too few cases | 7.5% | 8.6% |
| Heart bypass surgery (CABG) 48 cases | Too few cases | 2.7% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.14 likely 0.83 – 1.44 | 1 |
| After hip or knee replacement 182 cases | Too few cases | 3.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 86 cases | No different | 131.84 per 1,000 likely 82.64 per 1,000 – 181.05 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 6,197 cases | No different | 0.42 per 1,000 likely 0 per 1,000 – 1.02 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 7,857 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.38 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 8,283 cases | No different | 0.27 per 1,000 likely 0.08 per 1,000 – 0.46 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,673 cases | No different | 2.6 per 1,000 likely 1.14 per 1,000 – 4.06 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 694 cases | No different | 1.75 per 1,000 likely 0.19 per 1,000 – 3.32 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 728 cases | No different | 14.54 per 1,000 likely 7.77 per 1,000 – 21.31 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,823 cases | No different | 3.4 per 1,000 likely 1.42 per 1,000 – 5.37 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 664 cases | No different | 6.64 per 1,000 likely 2.91 per 1,000 – 10.37 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 327 cases | No different | 1.66 per 1,000 likely 0.18 per 1,000 – 3.15 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,237 cases | No different | 1.72 per 1,000 likely 0.76 per 1,000 – 2.68 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.5 likely 0.16 – 1.2 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.63 likely 0.28 – 1.25 | 1 |
| Surgical site infections after colon surgery | Better | 0 | 1 |
| MRSA bloodstream infections | Better | 0 | 1 |
| C. diff intestinal infections | Better | 0.21 likely 0.1 – 0.39 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 412 cases | Too few cases | 13.2% | 14.4% |
| Readmitted after heart failure 831 cases | Too few cases | 19.1% | 21.3% |
| Readmitted after pneumonia 978 cases | Too few cases | 18.5% | 17.3% |
| Readmitted after COPD 334 cases | Too few cases | 19.7% | 20% |
| Readmitted after heart bypass surgery 74 cases | Too few cases | 12.4% | 11% |
| Readmitted after hip or knee replacement 183 cases | Too few cases | 5.2% | 5.8% |
| Days back in hospital after a heart attack 269 cases | Too few cases | -4.3 days per 100 | — |
| Days back in hospital after heart failure 561 cases | Too few cases | -11 days per 100 | — |
| Days back in hospital after pneumonia 699 cases | Too few cases | 6.8 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,489 cases | No different | 11.5 per 1,000 likely 8.9 per 1,000 – 14.8 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 249 cases | No different | 9.9 per 100 likely 7.8 per 100 – 12.5 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 249 cases | No different | 4.6 per 100 likely 3.3 per 100 – 6.4 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,111 cases | No different | 0.8 likely 0.7 – 1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
272 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 110 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Anesthesiology | 34 |
| Nurse Anesthetist, Certified Registered | 26 |
| Internal Medicine | 19 |
| Emergency Medicine | 18 |
| Family | 13 |
| Diagnostic Radiology | 12 |
| Physician Assistant | 12 |
| Physical Therapist | 11 |
| Cardiovascular Disease | 9 |
| Dietitian, Registered | 9 |
| Anesthesiologist Assistant | 8 |
| Orthopaedic Surgery | 5 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $894,338
- 2020 $1.3M
- 2021 $841,852
- 2022 $856,326
- 2023 $883,325
- 2024 $767,218
- 2025 $636,566
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $37,542 | 1 |
| Space rental and facility fees | $9,000 | 3 |
| Medical devices and supplies on long-term loan | $5,360 | 1 |
| Debt forgiveness | $47 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $320,315 | 6 |
| AstraZeneca Pharmaceuticals LP | $135,229 | 2 |
| Merck Sharp & Dohme LLC | $50,686 | 8 |
| Gilead Sciences, Inc. | $46,542 | 4 |
| Novartis Pharmaceuticals Corporation | $42,557 | 1 |
| Stryker Corporation | $7,860 | 3 |
| Janssen Research & Development, LLC | $6,500 | 4 |
| Tolmar, INC. | $5,991 | 7 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion, of zongertinib (BI 1810631) as monotherapy in pat… Boehringer Ingelheim Pharmaceuticals, Inc. | $320,315 |
| a phase 3b,randomized,multicenter,open label study to assess the efficacy of durvalumab plus tremelimumab versus pembrolizumab in combination with pl… AstraZeneca Pharmaceuticals LP | $134,179 |
| A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cance… Novartis Pharmaceuticals Corporation | $42,557 |
| A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up… Merck Sharp & Dohme LLC | $19,476 |
| A Randomized, Phase 3, Open-label Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Pembrolizumab versus Intravenous Pembrolizumab… Merck Sharp & Dohme LLC | $12,143 |
| A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adult… Merck Sharp & Dohme LLC | $10,173 |
| A Phase 2 Study to Evaluate Patient Reported Preference for Subcutaneous Pembrolizumab Coformulated with Hyaluronidase MK-3475A Over Intravenous Pemb… Merck Sharp & Dohme LLC | $7,672 |
| TOL2506A-EXT TOLMAR, INC. | $5,566 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Holy Cross Hospital
Is Holy Cross Hospital a good hospital?
Holy Cross Hospital has a CMS overall rating of 4 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Holy Cross Hospital?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,092 completed HCAHPS surveys.
How long is the wait in the Holy Cross Hospital emergency room?
Emergency patients spend a median of 2 h 39 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Holy Cross Hospital receive money from drug and device companies?
Drug and device makers reported $636,566 in payments to Holy Cross Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.